University Of Michigan-Ann Arbor Awards Research Agreement Contract to Loxo Oncology Eli Lilly (June 2022)
- Approved
- Jun 16, 2022
The 30-second brief
University of Michigan approved project agreements with LOXO Oncology, Inc./Eli Lilly for research agreement 22-PAF05953. The funding support will not exceed the amount reported in Attachment A for each agreement and/or amendment.
Loxo Oncology Eli Lilly holds this research agreement contract with University Of Michigan-Ann Arbor.
See every contract and contact at University Of Michigan-Ann Arbor.
See every contractFree account · 30-second setup · No credit card
Contract details
- Contract type
- Research Agreement
- Document date
- June 16, 2022
- Term
- NA
- Vendor
- Loxo Oncology Eli Lilly
- Source document
- university-of-michigan-ann-arbor-meeting-minutes-2022-06-16_890.pdf (Meeting Minutes)
More University Of Michigan-Ann Arbor contracts
Questions about this contract
Who was awarded the research agreement contract by University Of Michigan-Ann Arbor?
Loxo Oncology Eli Lilly was awarded this research agreement contract by University Of Michigan-Ann Arbor, as recorded on June 16, 2022.
What type of contract is this?
This is a Research Agreement contract, documented as a meeting minutes record.
Where was this contract approved?
This contract appears in university-of-michigan-ann-arbor-meeting-minutes-2022-06-16_890.pdf (Meeting Minutes), dated June 16, 2022 from University Of Michigan-Ann Arbor. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Loxo Oncology Eli Lilly hold?
Loxo Oncology Eli Lilly may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is University Of Michigan-Ann Arbor currently buying?
Explore University Of Michigan-Ann Arbor's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.